Fibroblast transcriptomics in molecular diagnostics of a comprehensive dystonia cohort

Le résumé fourni par la source

Abstract Exome and genome sequencing leave >50% of dystonia-affected individuals without a molecular diagnosis. Where DNA-oriented approaches remain insufficient, integrating multiomics methods and bioinformatics is essential to advance genome interpretation. Herein, we incorporated RNA sequencing (RNA-seq) from a collection of 167 fibroblast samples from individuals affected with dystonic diseases. We leveraged an RNA-seq analysis pipeline, focused on the identification of expression and splicing aberrations, on RNA-seq from skin biopsies. We evaluated a “variant-positive” group of patient samples with preexisting information on variants (36/167, 21.6%), and a “variant-negative” group in which genomic sequencing alone had been unsuccessful in yielding a diagnostic candidate (78.4%). We found that at least 80% of dystonia-associated genes from databases were sufficiently detected by RNA-seq in fibroblasts, highlighting broad applicability. Expression and splicing aberration analyses then produced a manageable number of statistically significant RNA defects affecting dystonia-associated genes for effective case-by-case review. Our approach successfully detected RNA underexpression and mis-splicing for different types of pre-identified dystonia-related variants, providing both benchmarks and insights into mutational mechanisms. Applied to 131 samples from patients without candidate variants from exome and genome sequencing, RNA-seq aided the identification of previously unprioritized causative intronic alterations on reanalysis, providing an added diagnostic yield of 6.9% (9/131). For observed events, we also report the integration of new machine-learning scores predicting corresponding aberrant gene expression in the brain. Fibroblast-based RNA-seq in our selected cohort improved variant interpretation and enabled diagnoses missed by genomic analysis alone, suggesting this framework could be generalized to other dystonias.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.